NDC 50090-7576-01 - METFORMIN HYDROCHLORIDE
This NDC is not currently matched to an FDA NDC product listing in FDA.report, but it is a valid NDC-form code. FDA.report is showing the available DailyMed label context for the product root.
- Product NDC
- 50090-7576
- Requested NDC
- 50090-7576-01
- Package NDCs from labels
- 50090-7576-4, 50090-7576-2, 50090-7576-3, 50090-7576-0, 50090-7576-1, 50090-7576-01
- Manufacturer
- A-S Medication Solutions
- Effective date
- 2025-06-11
- Current FDA listing
- Not matched in FDA.report NDC product tables
DailyMed Labels#
| Label | Manufacturer | Effective date | Type |
|---|---|---|---|
| METFORMIN HYDROCHLORIDE - A-S Medication Solutions | A-S Medication Solutions | 2025-06-11 | Human Prescription Drug Label |
DailyMed Package Descriptions#
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 50090-7576-0 | METFORMIN HYDROCHLORIDE | 60 in 1 BOTTLE | TABLET, EXTENDED RELEASE | 60 | 1 | |
| 50090-7576-1 | METFORMIN HYDROCHLORIDE | 30 in 1 BOTTLE | TABLET, EXTENDED RELEASE | 30 | 1 | |
| 50090-7576-2 | METFORMIN HYDROCHLORIDE | 90 in 1 BOTTLE | TABLET, EXTENDED RELEASE | 90 | 1 | |
| 50090-7576-3 | METFORMIN HYDROCHLORIDE | 180 in 1 BOTTLE | TABLET, EXTENDED RELEASE | 180 | 1 | |
| 50090-7576-4 | METFORMIN HYDROCHLORIDE | 100 in 1 BOTTLE | TABLET, EXTENDED RELEASE | 100 | 1 |
DailyMed Billing Units#
| Package NDC | Billing unit | Product NDC | DailyMed indexing SPL | SPL version | Effective |
|---|---|---|---|---|---|
| 50090-7576-0 | EA - Each | 50090-7576 | 0c847ee5-b3fa-431c-8a21-4b7e282684fb | 1 | 2025-07-08 |
| 50090-7576-1 | EA - Each | 50090-7576 | fd37d81d-5ba6-4ff8-a246-19a6215f627c | 1 | 2025-07-08 |
| 50090-7576-2 | EA - Each | 50090-7576 | c1c75655-8fdf-4dac-a97f-71fe37d6d224 | 1 | 2025-07-08 |
| 50090-7576-3 | EA - Each | 50090-7576 | 028d035a-eb4b-4e00-b5fb-f91c8367bd8e | 1 | 2025-07-08 |
| 50090-7576-4 | EA - Each | 50090-7576 | 1bfb77b1-358a-4868-8541-f76f4c8a0d16 | 1 | 2025-07-08 |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| dapagliflozin and metformin hydrochloride | DAPAGLIFLOZIN AND METFORMIN HYDROCHLORIDE | Ascend Laboratories, LLC | eadcc3ef-f5c2-4a56-a6aa-12909844144e | 2026-03-18 | Boxed warning, Warnings, Adverse reactions | 786Z46389E |
| Metformin | METFORMIN ER 500 MG | Bryant Ranch Prepack | c047cf64-467a-40f3-be46-a1926b3b8d56 | 2026-03-17 | Warnings, Adverse reactions | 860975 786Z46389E |
| Lubricant Eye Drops | CARBOXYMETHYLCELLULOSE SODIUM | KC Pharmaceuticals, Inc. | 4d1d9b3a-ac5f-db27-e063-6294a90afc3f | 2026-03-16 | Warnings | K679OBS311 |
| Lubricant Eye Drops | CARBOXYMETHYLCELLULOSE SODIUM | Redicare LLC | 4d1e5089-22b0-7b3f-e063-6294a90a346a | 2026-03-16 | Warnings | K679OBS311 |
| Metformin Hydrochloride Oral Solution | METFORMIN HYDROCHLORIDE | MICRO LABS LIMITED | fb90693a-074a-45be-94f4-ed6298b1f4e4 | 2026-03-16 | Boxed warning, Warnings, Adverse reactions | 786Z46389E |
| Metformin HCL | METFORMIN HCL | Direct_Rx | 498ac5fc-14be-d36a-e063-6394a90a3012 | 2026-03-13 | Boxed warning, Warnings, Adverse reactions | 786Z46389E |
| METFORMIN HYDROCHLORIDE | METFORMIN HYDROCHLORIDE | PD-Rx Pharmaceuticals, Inc. | abd0dad9-5f29-4102-a099-dce7bdddb98b | 2026-03-13 | Boxed warning, Warnings, Adverse reactions | 786Z46389E |
| Metformin hydrochloride | METFORMIN HYDROCHLORIDE | Legacy Pharmaceutical Packaging, LLC | b51da8d7-ab4a-4c40-97c9-88bd379366d1 | 2026-03-11 | Boxed warning, Warnings, Adverse reactions | 786Z46389E |
| Metformin | METFORMIN ER 500 MG | Legacy Pharmaceutical Packaging, LLC | d9e0816d-fd61-1ac2-e053-2995a90a4054 | 2026-03-11 | Warnings, Adverse reactions | 860975 786Z46389E |
| Glipizide and Metformin Hydrochloride | GLIPIZIDE AND METFORMIN HYDROCHLORIDE | A-S Medication Solutions | 4a2d814b-93a1-4487-b789-dbafe9f0ffd3 | 2026-03-07 | Boxed warning, Warnings, Adverse reactions | 786Z46389E |
| Rain Renewal Eye Drops | CARBOXYMETHYLCELLULOSE SODIUM | Rain Eye Drops, LLC | bb451b22-c4f6-291d-e053-2a95a90a7801 | 2026-03-06 | Warnings | K679OBS311 |
| METFORMIN HYDROCHLORIDE | METFORMIN HYDROCHLORIDE | direct rx | c33e24e9-0441-6b94-e053-2a95a90a9c68 | 2026-03-05 | Boxed warning, Warnings, Adverse reactions | 786Z46389E |
| glyburide-metformin hydrochloride | GLYBURIDE-METFORMIN HYDROCHLORIDE | A-S Medication Solutions | f43c087a-7135-4a79-8463-fe5e9319da91 | 2026-03-03 | Boxed warning, Warnings, Adverse reactions | 786Z46389E |
| METFORMIN HYDROCHLORIDE | METFORMIN HYDROCHLORIDE | A-S Medication Solutions | 75b25738-31e6-4b58-9d2b-f4a1ab4ab090 | 2026-03-03 | Boxed warning, Warnings, Adverse reactions | ANDA217631 860975 786Z46389E |
| Refresh Optive Mega-3 PF | CARBOXYMETHYLCELLULOSE SODIUM, GLYCERIN, POLYSORBATE 80 | Allergan, Inc. | 326cb5d6-c784-404f-9a13-6d69262dda6e | 2026-03-01 | Warnings | K679OBS311 |
| Discount Drug Mart Lubricant Eye Drops | CARBOXYMETHYLCELLULOSE SODIUM | Discount Drug Mart | 4ba1b369-54e2-5224-e063-6394a90a4769 | 2026-02-25 | Warnings | K679OBS311 |
| Metformin Hydrochloride Oral Solution | METFORMIN HYDROCHLORIDE | Bionpharma Inc., | 3ab005d4-bc99-4fdb-e063-6394a90a5124 | 2026-02-25 | Boxed warning, Warnings, Adverse reactions | 786Z46389E |
| Lubricant Eye Drops | CARBOXYMETHYLCELLULOSE SODIUM | KC Pharmaceuticals, Inc. | 4bafa882-50b7-e3e2-e063-6294a90a76e3 | 2026-02-25 | Warnings | K679OBS311 |
| Metformin Hydrochloride | METFORMIN HYDROCHLORIDE | Method Pharmaceuticals, LLC. | 4aa880a4-7ec0-9155-e063-6394a90a8f3e | 2026-02-09 | Boxed warning, Warnings, Adverse reactions | 786Z46389E |
| Glyburide and Metformin Hydrochloride | GLYBURIDE AND METFORMIN HYDROCHLORIDE | A-S Medication Solutions | d87dade1-55fe-4e77-91b9-b642022a2b8a | 2026-02-08 | Boxed warning, Warnings, Adverse reactions | 786Z46389E |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.